100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
You Searched


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
Customers also bought
More About Sitaglip D 10/100mg Tablet 10s
Sitaglip D 10 100mg Tablet 10s is an oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus (T2DM) in adults. It combines Dapagliflozin, an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor, and Sitagliptin, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor. Dapagliflozin helps lower blood sugar by increasing the excretion of glucose through urine, while Sitagliptin enhances insulin secretion and reduces glucagon release in a glucose-dependent manner. Together, they provide complementary blood sugar control, helping improve both fasting and post-meal glucose levels with a low risk of hypoglycaemia when used appropriately.
Sitaglip D 10 100mg Tablet 10s is an oral anti-diabetic medication designed to help adults with Type 2 Diabetes Mellitus (T2DM) achieve better blood sugar control. It combines Dapagliflozin, an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor, with Sitagliptin, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor. This combination targets high blood sugar through complementary mechanisms.
Dapagliflozin works in the kidneys by preventing glucose reabsorption, promoting the removal of excess glucose through urine. This process lowers blood sugar independently of insulin and may also support modest weight loss and help control blood pressure.
Sitagliptin enhances the activity of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP), which are released after meals. These hormones increase insulin secretion and reduce glucagon release in a glucose-dependent manner, helping the body manage post-meal blood sugar effectively while minimising the risk of low blood sugar (hypoglycaemia).
By combining these two medicines, Sitaglip D 10 100mg Tablet 10s addresses both insulin-dependent and insulin-independent pathways. This helps reduce both fasting and post-meal glucose levels, providing stable and sustained glycemic control throughout the day. The combination supports long-term management of diabetes and may help reduce the risk of complications affecting the eyes, kidneys, nerves, and cardiovascular system.
Sitaglip D 10 100mg Tablet 10s is generally well tolerated when used as prescribed. It should be taken as directed by a healthcare professional, usually with or after meals, to improve tolerability and minimise gastrointestinal discomfort. Regular monitoring of blood sugar and kidney function is recommended during treatment.
Sitaglip D 10 100mg Tablet 10s is indicated for:
When taken as directed, Sitaglip D 10 100mg Tablet 10s is generally well-tolerated. Side effects are typically mild and often diminish as the body adjusts to the medication.
Not recommended during the second and third trimesters of pregnancy.
Use is not recommended as it is unknown if the components pass into breast milk.
Does not affect driving ability directly, but be aware of hypoglycemia signs if taking other medications.
Use with care in patients with severe hepatic impairment.
Effectiveness depends on kidney function; not recommended for patients with severe renal failure or on dialysis.
Avoid excessive alcohol intake as it can increase the risk of ketoacidosis or dehydration.
Can be taken with or without food.
Medication should be used alongside a healthy diet and regular physical activity.
Store in a cool, dry place below 30°C. Protect from moisture and light by keeping tablets in their original blister pack. Keep away from children.
Standard dosing is usually one tablet once daily. Follow the specific instructions provided by your healthcare provider.
An overdose can lead to severe dehydration or gastrointestinal distress. Action Required: Seek emergency medical care or contact a poison control centre immediately if an overdose is suspected.
Take the missed dose as soon as you remember. If it is nearly time for the next dose, skip the missed one. Never "double up" on doses.
https://medlineplus.gov/druginfo/meds/a606023.html
https://go.drugbank.com/drugs/DB01261
https://pubchem.ncbi.nlm.nih.gov/compound/Sitagliptin
https://medlineplus.gov/druginfo/meds/a614015.html
https://www.mayoclinic.org/drugs-supplements/dapagliflozin-oral-route/description/drg-20095101
https://pubchem.ncbi.nlm.nih.gov/compound/Dapagliflozin
https://go.drugbank.com/drugs/DB06292
Therapeutic Class
Anti-diabetic Agent
Action Class
Increases Glucose-dependent Insulin Secretion + Increases Renal Glucose Excretion
Chemical Class
DPP-4 (Dipeptidyl Peptidase-4) Inhibitor + SGLT2 (Sodium-Glucose Co-Transporter 2) Inhibitor
Habit Forming
No
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Top Selling Medicines
Top Selling Devices
Flat ₹100 off on first app order | Use Code: APP100 |
Flat ₹100 off on first app order
USE CODE: APP100

Download Now